<DOC>
<DOCNO>
EP-0015436
</DOCNO>
<TEXT>
<DATE>
19800917
</DATE>
<IPC-CLASSIFICATIONS>
C07C-46/06 C07C-37/11 C07C-46/00 C07F-11/00 C07C-11/00 C07C-1/00 <main>C07C-50/14</main> C07C-1/32 C07C-11/28 C07C-11/22 
</IPC-CLASSIFICATIONS>
<TITLE>
process for the stereospecific preparation of compounds of the vitamin k1- and k2-series, as well as new starting materials for the process.
</TITLE>
<APPLICANT>
hoffmann la rochech<sep>f.hoffmann-la roche & co. aktiengesellschaft<sep>f. hoffmann-la roche &amp; co. aktiengesellschaftpostfach 32554002 baselch<sep>f. hoffmann-la roche & co. aktiengesellschaft <sep>
</APPLICANT>
<INVENTOR>
dotz karl heinz dr<sep>dotz, karl heinz, dr.<sep>dötz, karl heinz, dr.zeisigstrasse 30ed-8011 vaterstettende<sep>dotz, karl heinz, dr.<sep>dötz, karl heinz, dr.zeisigstrasse 30ed-8011 vaterstettende<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to a new method for producing compounds of the vitamin K₁ and K₂ series in particular in the form of the E-isomers.The method is that a phenyl-carbon-carbonyl-metal complex of the formula having an enin of formula CH₃-C≡C-R₂ II is converted into a compound of the formula.Subsequently, the metal ring bond is cleaved and, if necessary, oxidizes the naphtholder derivative obtained.In formulas I, II and III, R¹ is lower alkyl, acyl or benzyl and R² a dimethylallyl, geranyl, fernesyl or analogous isoprenoid terpenyl radical or the phytyl radical.The invention further relates to novel compounds of the formula CH₃-C≡C-R 2, wherein R² represents a geranyl, farnesyl or analog isoprenoid terpenyl radical and the phytyl radical and the formula where R¹ and R² have the above meaning.
</ABSTRACT>
</TEXT>
</DOC>
